Webinar Registration
Available On-demand
Vaccines are immunological products aimed at preventing diseases from onslaught or reducing their severity. Prepared from biological products such as heat-killed or attenuated microbes, proteins, polysaccharides, and nucleic acids, this class of biopharmaceuticals has played a vital role in containing diseases and reducing their spread in the community, including the recent COVID -19 pandemic. This webinar aims to present a fresh perspective to this age-old immunization process (since Edward Jenner’s cowpox vaccine), by showcasing the use of cutting-edge technology from Shimadzu in the development and Quality Control of vaccines production with some real-life case studies from the India market. At the end of the presentation, we will have a panel discussion whereby experts from the vaccine industry will share viewpoints on the general trends and challenges on Vaccine Analytics.
Learning Objectives:
Mr. Ashutosh Shelar
Sr. Marketing Executive (CRO & Biopharma)
Shimadzu Analytical India
Mr. Ashutosh Shelar completed his Masters in Bioanalytical Sciences from Mumbai university. He spent initial 7 years in CRO industry as a research scientist in bioanalytical lab developing and validating methods for small drug molecules. He has been working with Shimadzu analytical India for 6 years, with different responsibilities catering to applications and marketing for CRO and biopharma segments across India.
Dr. Wang Tianhua
Product Specialist
Shimadzu Asia Pacific
Tianhua did his PhD in University of Pennsylvania (Chemical and Biomolecular Engineering). He then spent 5 years in the analytics group at Bioprocessing Technology Institute. His research interest includes drug discovery for infectious disease (SARS-CoV and Ebola), biopharmaceutical production system optimization and mAb Characterization with particular focus in glycan profiling and glycomics study. Tianhua joined Shimadzu in 2017 as a product specialist for life science products.